bpc 157 human evidence safety fda warning Heal or Harm: Body Protective Compound-157 in the Gray Zone FDA Scientists Warn Against Expanded
Description
Patients with early hereditary optic nerve atrophy, cyanocobalmin hypersensitivity, and those who are pregnant

A patient with a history of Lebers disease is not a suitable candidate for vitamin B12 injection

Abels, Improved distribution analysis of cobalamins and cobalamin analogues in human plasma in which the use of thiol-blocking agents is a prerequisite, Clinica Chimica Acta, Volume 131, Issue 3, 15 July 1983, Pages 211-224, ISSN 0009-8981 Thakkar, K., & Billa, G
Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold
